AXCELIS TECHNOLOGIES INC (ACLS) Fundamental Analysis & Valuation

NASDAQ:ACLS • US0545402085

Current stock price

143.13 USD
+3.27 (+2.34%)
At close:
143.13 USD
0 (0%)
After Hours:

This ACLS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ACLS Profitability Analysis

1.1 Basic Checks

  • In the past year ACLS was profitable.
  • ACLS had a positive operating cash flow in the past year.
  • In the past 5 years ACLS has always been profitable.
  • In the past 5 years ACLS always reported a positive cash flow from operatings.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

  • ACLS's Return On Assets of 8.83% is fine compared to the rest of the industry. ACLS outperforms 79.13% of its industry peers.
  • The Return On Equity of ACLS (11.62%) is better than 75.65% of its industry peers.
  • ACLS's Return On Invested Capital of 8.93% is fine compared to the rest of the industry. ACLS outperforms 78.26% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACLS is significantly above the industry average of 10.92%.
  • The 3 year average ROIC (16.09%) for ACLS is well above the current ROIC(8.93%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROIC 8.93%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • ACLS's Profit Margin of 14.33% is fine compared to the rest of the industry. ACLS outperforms 73.91% of its industry peers.
  • In the last couple of years the Profit Margin of ACLS has grown nicely.
  • Looking at the Operating Margin, with a value of 14.22%, ACLS is in the better half of the industry, outperforming 72.17% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ACLS has grown nicely.
  • Looking at the Gross Margin, with a value of 44.91%, ACLS is in line with its industry, outperforming 53.04% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACLS has remained more or less at the same level.
Industry RankSector Rank
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ACLS Health Analysis

2.1 Basic Checks

  • ACLS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ACLS has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ACLS has been reduced compared to 5 years ago.
  • The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • ACLS has an Altman-Z score of 9.97. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 9.97, ACLS is in the better half of the industry, outperforming 66.09% of the companies in the same industry.
  • ACLS has a debt to FCF ratio of 0.40. This is a very positive value and a sign of high solvency as it would only need 0.40 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.40, ACLS belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that ACLS is not too dependend on debt financing.
  • ACLS has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: ACLS outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Altman-Z 9.97
ROIC/WACC0.73
WACC12.17%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 4.77 indicates that ACLS has no problem at all paying its short term obligations.
  • ACLS has a better Current ratio (4.77) than 70.43% of its industry peers.
  • ACLS has a Quick Ratio of 3.11. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ACLS (3.11) is better than 63.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.77
Quick Ratio 3.11
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ACLS Growth Analysis

3.1 Past

  • ACLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.81%.
  • The Earnings Per Share has been growing by 29.06% on average over the past years. This is a very strong growth
  • The Revenue for ACLS has decreased by -17.57% in the past year. This is quite bad
  • Measured over the past years, ACLS shows a quite strong growth in Revenue. The Revenue has been growing by 12.07% on average per year.
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%

3.2 Future

  • Based on estimates for the next years, ACLS will show a decrease in Earnings Per Share. The EPS will decrease by -2.80% on average per year.
  • Based on estimates for the next years, ACLS will show a small growth in Revenue. The Revenue will grow by 5.32% on average per year.
EPS Next Y-23.59%
EPS Next 2Y-2.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.78%
Revenue Next 2Y5.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. ACLS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 29.39, ACLS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 87.83% of the companies listed in the same industry.
  • ACLS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.42.
  • Based on the Price/Forward Earnings ratio of 38.46, the valuation of ACLS can be described as expensive.
  • 67.83% of the companies in the same industry are more expensive than ACLS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, ACLS is valued quite expensively.
Industry RankSector Rank
PE 29.39
Fwd PE 38.46
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACLS indicates a rather cheap valuation: ACLS is cheaper than 80.87% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ACLS is valued cheaply inside the industry as 83.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 41.1
EV/EBITDA 27.29
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The excellent profitability rating of ACLS may justify a higher PE ratio.
  • A cheap valuation may be justified as ACLS's earnings are expected to decrease with -2.80% in the coming years.
PEG (NY)N/A
PEG (5Y)1.01
EPS Next 2Y-2.8%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ACLS Dividend Analysis

5.1 Amount

  • No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACLS Fundamentals: All Metrics, Ratios and Statistics

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (4/24/2026, 8:20:03 PM)

After market: 143.13 0 (0%)

143.13

+3.27 (+2.34%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-17
Earnings (Next)05-06
Inst Owners108.05%
Inst Owner Change0.13%
Ins Owners0.56%
Ins Owner Change-2.07%
Market Cap4.40B
Revenue(TTM)839.05M
Net Income(TTM)120.24M
Analysts50.91
Price Target107.25 (-25.07%)
Short Float %12.43%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.43%
Min EPS beat(2)18.27%
Max EPS beat(2)30.58%
EPS beat(4)4
Avg EPS beat(4)66.14%
Min EPS beat(4)18.27%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)40.33%
EPS beat(12)12
Avg EPS beat(12)31.33%
EPS beat(16)16
Avg EPS beat(16)28.84%
Revenue beat(2)2
Avg Revenue beat(2)6.67%
Min Revenue beat(2)4.69%
Max Revenue beat(2)8.66%
Revenue beat(4)4
Avg Revenue beat(4)4.62%
Min Revenue beat(4)2.12%
Max Revenue beat(4)8.66%
Revenue beat(8)7
Avg Revenue beat(8)2.58%
Revenue beat(12)11
Avg Revenue beat(12)2.76%
Revenue beat(16)15
Avg Revenue beat(16)2.72%
PT rev (1m)0%
PT rev (3m)-1.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-32.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.06%
Valuation
Industry RankSector Rank
PE 29.39
Fwd PE 38.46
P/S 5.24
P/FCF 41.1
P/OCF 37.18
P/B 4.25
P/tB 4.25
EV/EBITDA 27.29
EPS(TTM)4.87
EY3.4%
EPS(NY)3.72
Fwd EY2.6%
FCF(TTM)3.48
FCFY2.43%
OCF(TTM)3.85
OCFY2.69%
SpS27.3
BVpS33.67
TBVpS33.67
PEG (NY)N/A
PEG (5Y)1.01
Graham Number60.7403 (-57.56%)
Profitability
Industry RankSector Rank
ROA 8.83%
ROE 11.62%
ROCE 10.25%
ROIC 8.93%
ROICexc 13.17%
ROICexgc 13.17%
OM 14.22%
PM (TTM) 14.33%
GM 44.91%
FCFM 12.75%
ROA(3y)14.31%
ROA(5y)14.82%
ROE(3y)19.98%
ROE(5y)21.14%
ROIC(3y)16.09%
ROIC(5y)18.16%
ROICexc(3y)30.86%
ROICexc(5y)36.82%
ROICexgc(3y)30.86%
ROICexgc(5y)36.82%
ROCE(3y)18.46%
ROCE(5y)20.85%
ROICexgc growth 3Y-38.1%
ROICexgc growth 5Y-2.58%
ROICexc growth 3Y-38.1%
ROICexc growth 5Y-2.58%
OM growth 3Y-14.92%
OM growth 5Y3.08%
PM growth 3Y-10.37%
PM growth 5Y6.35%
GM growth 3Y0.94%
GM growth 5Y1.43%
F-Score5
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.4
Debt/EBITDA 0.3
Cap/Depr 64.13%
Cap/Sales 1.35%
Interest Coverage 26.09
Cash Conversion 86.4%
Profit Quality 89%
Current Ratio 4.77
Quick Ratio 3.11
Altman-Z 9.97
F-Score5
WACC12.17%
ROIC/WACC0.73
Cap/Depr(3y)99.74%
Cap/Depr(5y)94.41%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.37%
Profit Quality(3y)69.44%
Profit Quality(5y)92.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.81%
EPS 3Y-3.74%
EPS 5Y29.06%
EPS Q2Q%-3.25%
EPS Next Y-23.59%
EPS Next 2Y-2.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.57%
Revenue growth 3Y-3.02%
Revenue growth 5Y12.07%
Sales Q2Q%-5.58%
Revenue Next Year2.78%
Revenue Next 2Y5.32%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.57%
EBIT growth 3Y-17.49%
EBIT growth 5Y15.52%
EBIT Next Year-9.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.81%
FCF growth 3Y-19.47%
FCF growth 5Y11.43%
OCF growth 1Y-15.99%
OCF growth 3Y-18.13%
OCF growth 5Y11.16%

AXCELIS TECHNOLOGIES INC / ACLS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACLS.


What is the valuation status of AXCELIS TECHNOLOGIES INC (ACLS) stock?

ChartMill assigns a valuation rating of 5 / 10 to AXCELIS TECHNOLOGIES INC (ACLS). This can be considered as Fairly Valued.


How profitable is AXCELIS TECHNOLOGIES INC (ACLS) stock?

AXCELIS TECHNOLOGIES INC (ACLS) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for ACLS stock?

The Price/Earnings (PE) ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 29.39 and the Price/Book (PB) ratio is 4.25.